Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



QuantWave Achieves 22.53% Profit Target Forecast for CVS HEALTH CORPORATION

December 17, 2024
QuantWave, the automated forecasting platform, has successfully hit its price target forecast for CVS HEALTH CORPORATION, with a profit of 22.53% realized. The forecast signal, issued on October 22, 2024, indicated a short direction with the stock priced at 55.56 $. On December 17, 2024, the target price of 43.04 $ was reached, validating QuantWave's analytics.

Market analysis suggests that potential factors contributing to the stock's movement could include changes in the healthcare sector, company performance, and broader market conditions. The achievement of this forecast highlights the accuracy and value of QuantWave's predictive capabilities, providing users with opportunities for profitable trading decisions.

QuantWave offers a wide range of stock predictions for investors seeking to capitalize on market movements. For those interested in delving deeper into investment strategies, QuantSchool provides educational resources on utilizing the QuantWave forecasting system effectively. By understanding the key principles outlined in QuantSchool, investors can generate consistent income through informed decision-making.
If you want to leave a comment, then you need Login or Register





Other data for CVS

Related data

CVSJuly 3, 2025CVS Health Corporation NYSE:CVS Shares Sold by Trust Co. of Vermont  ~1 min.

Trust Co. of Vermont recently sold a number of shares in CVS Health Corporation, a leading healthcare company....


CVSMarch 20, 2025CVS Health Corporation Stock Hits QuantWave Forecast Target with 17.61% Profit  ~1 min.

QuantWave, the automated forecasting platform, recently achieved a significant success with its price target forecast for CVS Health Corporation....


CVSMarch 19, 2025CVS Health becomes first company in the U.S. to earn menopause-friendly accreditation  ~2 min.

CVS Health Corporation announced today that it has become the first company in the United States to receive the prestigious menopause-friendly accreditation....


CVSMarch 19, 2025CVS HEALTH CORPORATION Hits Price Target Forecast with 16.35% Profit: A Success Story for QuantWave  ~2 min.

On June 25, 2024, QuantWave, an automated forecasting platform, issued a long signal for CVS HEALTH CORPORATION stock when it was trading at $57.77. Fast forward to March 19, 2025, the target price of $67....


CVSFebruary 26, 2025CVS Health Revamps Strategy As It Trims Employee Bonuses  ~2 min.

CVS Health Corporation, one of the leading healthcare companies in the United States, is making significant changes to its business strategy....


CVSFebruary 25, 2025CVS Health: 3 steps to achieving health equity accreditation  ~1 min.

CVS Health Corporation is taking significant steps towards achieving health equity accreditation....


CVSFebruary 23, 2025CVS Health Corporation: A Leader in Achieving Health Equity Accreditation  ~2 min.

CVS Health Corporation (NYSE: CVS) has recently taken significant steps towards achieving health equity accreditation, solidifying its position as a leader in the healthcare industry....


CVSFebruary 19, 2025CVS Health Reports Strong Q4 Sales Earnings, Stock Surges  ~2 min.

CVS Health Corporation, a leading healthcare company, announced its fourth quarter and full-year 2024 results, exceeding market expectations. The company reported a 4.2% increase in revenue to $97....


CVSFebruary 16, 2025CVS Health Corporation Reports Strong Q4 Earnings: Analysts Predict Positive Future  ~2 min.

CVS Health Corporation, a leading healthcare company, has just released their fourth-quarter and full-year 2024 financial results....


CVSFebruary 14, 2025CVS Health Corp. Reports Strong Fourth Quarter and Full-Year 2024 Results  ~2 min.

CVS Health Corporation, a leading healthcare company, announced its fourth-quarter and full-year 2024 financial results today. The company reported a revenue increase of 4.2%, reaching $97....


ABTFebruary 20, 2025ABBOTT LABORATORIES Achieves Price Target Forecast with 15.9% Profit  ~1 min.

QuantWave's forecast for ABBOTT LABORATORIES reached its target on February 20, 2025, generating a profit of 15.9%. The forecast signal date was December 10th, 2024, with a price of $114....


UNHJuly 17, 2024UNITEDHEALTH GROUP INCORPORATED Hits Price Target Forecast with 8.38% Profit  ~1 min.

UNITEDHEALTH GROUP INCORPORATED has successfully reached the price target forecast provided by QuantWave on July 17, 2024....


CVSOctober 14, 2024CVS Health Corporation Hits Price Target Forecast with 20.85% Profit Gain  ~1 min.

QuantWave, the automated forecasting platform, successfully identified a long signal for CVS Health Corporation on August 13, 2024, when the stock was priced at 53.96 $....


UNHApril 10, 2024UNITEDHEALTH GROUP INCORPORATED Hits Price Target Forecast with 10.41% Profit Margin  ~2 min.

UNITEDHEALTH GROUP INCORPORATED (UNH) has successfully reached the price target forecast as predicted by QuantWave on August 11, 2023. The forecast indicated a short direction with a price of $494....


UNHJuly 17, 2024UNITEDHEALTH GROUP INCORPORATED Hits Price Target Forecast, Generating 16.02% Profit  ~1 min.

On June 11, 2024, QuantWave issued a long signal for UNITEDHEALTH GROUP INCORPORATED when the stock was trading at $488.41. Fast forward to July 17, 2024, the price target of $566....